unapproved substance is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-07-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
| Property | Value | Notes |
|---|---|---|
| Common name | Cardarine | Common internet and media name. |
| Research code | GW501516 | Also written GW-1516. |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator. |
| Development status | Discontinued | Clinical development halted after rodent cancer findings. |
| Regulatory status | Prohibited in sport | Listed by WADA; not approved as medicine. |
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
=== Therapy === Intravenous magnesium is recommended by the ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death for patients with ventricular arrhythmia associated with torsades de pointes who present with long QT syndrome; and for the treatment of patients with digoxin-induced arrhythmias. Intravenous magnesium sulfate is used for the management of pre-eclampsia and eclampsia. Hypomagnesemia, including that caused by alcoholism, is reversible by oral or parenteral magnesium administration depending on the degree of deficiency. There is limited evidence that magnesium supplementation may play a role in the prevention and treatment of migraine.
Gee highlighted particular success with a child fed "a quart of the best Dutch mussels daily"; the child could not bear this diet for more than one season. Christian Archibald Herter, an American physician, wrote a book in 1908 on children with coeliac disease, which he called "intestinal infantilism". He noted their growth was retarded and that fat was better tolerated than carbohydrate. The eponym Gee-Herter disease was sometimes used to acknowledge both contributions. Sidney V. Haas, an American paediatrician, reported positive effects of a diet of bananas in 1924. This diet remained in vogue until the actual cause of coeliac disease was determined. While a role for carbohydrates had been suspected, the link with wheat was not made until the 1940s by the Dutch paediatrician Willem Karel Dicke. Clinical improvement of his patients during the Dutch famine of 1944–1945 (during which flour was scarce) likely contributed to his discovery. Dicke noticed that the shortage of bread led to a significant drop in the death rate among children affected by coeliac disease from greater than 35% to essentially zero. He also reported that once wheat was again available after the conflict, the mortality rate soared to previous levels. The link with the gluten component of wheat was made in 1952 by a team from Birmingham, England. Villous atrophy was described by British physician John W. Paulley in 1954 on samples taken at surgery. This encouraged biopsy samples taken by endoscopy. Throughout the 1960s, other features of coeliac disease were elucidated.
== Structure == The basement membrane was first described in skeletal muscle tissue in the 1800s. The beginnings of a molecular understanding only came about in the 1970s and 1980s. Epithelial cells are polarized. The surface of epithelial cells that face the lumen is the apical surface, and the surface facing the basement membrane is the basal surface. The basement membrane may be described as having two layers or laminae, an external basal lamina, facing the epithelium, and an internal basal lamina that faces the connective tissue. These two laminae are also known as the basal lamina and the reticular lamina. The cells in the internal basal membrane that are closest to the connective tissue show high rates of mitosis, needed to replace skin cell abrasions, and in the GI tract replacement of the cells exposed to digestive enzymes and gastric acid. In the skin the basement membrane is part of a more complex basement membrane zone. In the mucous membrane linings such as the gastric mucosa the basement membrane overlies loose connective tissue known as the lamina propria. The basement membrane is synthesized by cells on either side. One set of components are synthesized from the basal epithelial cells, and the other comes from the underlying connective tissue. Together the basement membrane contains glycoproteins – laminins, type IV collagen, and nidogen, and proteoglycans – perlecan, heparan sulfate proteoglycan, and agrin that blend together. Other components may include fibronectin and type XVIII collagen.
=== Pancreatic === Although most of the glucokinase in the body is in the liver, smaller amounts in the beta and alpha cells of the pancreas, certain hypothalamic neurons, and specific cells (enterocytes) of the gut play an increasingly appreciated role in regulation of carbohydrate metabolism. In the context of glucokinase function, these cell types are collectively referred to as neuroendocrine tissues, and they share some aspects of glucokinase regulation and function, especially the common neuroendocrine promoter. Of the neuroendocrine cells, the beta cells of the pancreatic islets are the most-studied and best-understood. It is likely that many of the regulatory relationships discovered in the beta cells will also exist in the other neuroendocrine tissues with glucokinase.
Arsène Wenger management career statistics at Soccerbase Arsène Wenger manager profile at J.League (archive) (in Japanese) Arsène Wenger profile at Arsenal.com Arsène Wenger at Soccerway.com Arsène Wenger at WorldFootball.net Arsène Wenger at Soccerbase.com (manager) Arsène Wenger at J.League (manager) (in Japanese) Arsène Wenger at L'Équipe (in French)
Sources: en.wikipedia.org
Pearly penile papules are raised bumps of somewhat paler color around the base (sulcus) of the glans, which typically develop in males aged 20 to 40. As of 1999, different studies had produced estimates of incidence ranging from 8 to 48 percent of all men. They may be mistaken for warts, but are not harmful or infectious and do not require treatment. Fordyce's spots are small, raised, yellowish-white spots 1–2 mm (roughly 0.05 inch) in diameter that may appear on the penis, which again are common and not infectious. Sebaceous prominences are raised bumps similar to Fordyce's spots on the shaft of the penis, located at the sebaceous glands and are normal. Phimosis is an inability to retract the foreskin fully. It is normal and harmless in infancy and pre-pubescence, occurring in about 8% of boys at age 10. According to the British Medical Association, treatment (topical steroid cream and/or manual stretching) does not need to be considered until age 19. Curvature: few penises are completely straight, with curves commonly seen in all directions (up, down, left, right). Sometimes the curve is very prominent but it rarely inhibits sexual intercourse. Curvature as great as 30° is considered normal and medical treatment is rarely considered unless the angle exceeds 45°. Changes to the curvature of a penis may be caused by Peyronie's disease.
21 July – Writing in the Sun on Sunday, Home Secretary Yvette Cooper announces that car washes and beauty salons will be targeted by immigration officials over the summer in a bid to crack down on businesses illegally hiring workers from overseas. Former Chancellor Jeremy Hunt, who was Health Secretary for a number of years before the COVID-19 pandemic, apologises "unreservedly" to the families of people who died from the illness after a report prepared by the COVID-19 Inquiry found significant flaws in the government's strategy for dealing with the pandemic. 22 July – Home Secretary Yvette Cooper confirms the UK government will resume processing asylum applications, including those from people who arrived in the UK illegally. She also tells the House of Commons the previous government's Rwanda asylum plan cost £700m, with only four people being removed to the country voluntarily. The shadow home secretary, James Cleverly, says Cooper's words are "hyperbole" and "made up numbers", adding that Labour had scrapped scheme on "ideological grounds" and that its purpose was as a deterrent. Launch of Skills England, a government body whose objective will be to reduce the need for overseas employees by improving skills training for people in England. 2024 Conservative Party leadership election: The Conservative Party's 1922 Committee sets out a timeline for the election of the next leader, with the successful candidate scheduled to be announced in early November. July 2024 Welsh Labour leadership election: Eluned Morgan becomes the first candidate to enter the leadership race.
The US Food and Drug Administration (FDA) approves anti-obesity medications as an adjunctive therapy to diet and exercise for people for whom lifestyle changes do not result in sufficient weight loss. In the United States, semaglutide (Wegovy) is approved by the FDA for chronic weight management. The FDA guidelines say that a therapy may be approved if it results in weight loss that is statistically significant greater than placebo and generally at least five percent of body weight over six months that comes predominantly from fat mass. Some other prescription weight loss medications are stimulants, which are recommended only for short-term use, and thus are of limited usefulness for patients who may need to reduce weight over months or years. As of 2022, there is no pathway for approval for drugs that reduce fat mass without 5 percent overall weight loss, even if they significantly improve metabolic health; neither is there one for drugs that help patients maintain weight loss although this can be more challenging than losing weight. As of 2022, no medication has been discovered that would equal the effectiveness of bariatric surgery for long-term weight loss and improved health outcomes.
== External links == Spallation Neutron Source Mercury 197 Mercury 197 decays to Gold 197 Kolarik, Zdenek; Renard, Edouard V. (2003). "Recovery of Value Fission Platinoids from Spent Nuclear Fuel. Part I PART I: General Considerations and Basic Chemistry" (PDF). Platinum Metals Review. 47 (2): 74–87. doi:10.1595/003214003X4727487. Archived from the original (PDF) on 2011-06-09. Kolarik, Zdenek; Renard, Edouard V. (2003). "Recovery of Value Fission Platinoids from Spent Nuclear Fuel. Part II: Separation Process" (PDF). Platinum Metals Review. 47 (2): 123–131. doi:10.1595/003214003X473123131. Archived from the original (PDF) on 2011-06-09. Kolarik, Zdenek; Renard, Edouard V. (2005). "Potential Applications of Fission Platinoids in Industry". Platinum Metals Review. 49 (2): 79. doi:10.1595/147106705X35263.
Sources: en.wikipedia.org
The successes of Josip Broz Tito's Yugoslav partisans in Dalmatia led the Allies to despatch small patrols into Yugoslavia and Albania to contact partisan leaders and arrange co-operation with the Allied air forces. Several Rhodesian patrols from the LRDG were selected to undertake such missions during August and September 1944. Yugoslav partisans subsequently indicated targets for Allied bombing missions, with some success. From September, members of the LRDG's Rhodesian squadron under Captain Olivey undertook advanced reconnaissance in the Peloponnese peninsula of southern Greece. Landing at Katakolo, they made their way inland to Corinth and, along with the British 4th Parachute Battalion, entered Athens as the Germans departed in November. The Rhodesians of the LRDG spent November and December helping Greek forces to garrison an Athens orphanage against supporters of the communist Greek People's Liberation Army. Four Rhodesians were killed. The LRDG returned to Yugoslavia in February 1945, operating around Istria and Dalmatia, where Germany still held portions of the mainland and certain strategic islands. The Germans had heavily mined the southern Adriatic and were attempting to cover their shipping by moving only by night, close to shore, and heaving to during the day under camouflage nets. The LRDG was tasked to patrol the coast, find the ships and report their locations to the air force for bombing. This it did with success. It remained in Yugoslavia for the rest of the war.
=== Chronic pain === Chronic pain continues to be regarded as the core characteristic of fibromyalgia. According to the NHS, widespread pain is a major symptom, which could feel like an ache, a burning sensation, or a sharp, stabbing pain. Patients are also susceptible to pain, and the slightest touch can cause pain. Pain also tends to linger for a longer period when a patient experiences it. The pain associated with fibromyalgia is often a constant dull ache that has lasted for at least three months, occurring on both sides of the body and above and below the waist. Pain in fibromyalgia may include contributions from central pain, peripheral musculoskeletal pain generators, neuropathic pain, and other pathways. Men may be affected by FM pain differently to women.
== Etymology and central beliefs == Effective accelerationism, a portmanteau of "effective altruism" and "accelerationism", is a fundamentally techno-optimist movement. According to Guillaume Verdon, one of the movement's founders, its aim is for human civilization to "clim[b] the Kardashev gradient", meaning its purpose is for human civilization to rise to next levels on the Kardashev scale by maximizing energy usage. To achieve this goal, effective accelerationism wants to accelerate technological progress. It is strongly focused on artificial general intelligence (AGI), because it sees AGI as fundamental for climbing the Kardashev scale. The movement therefore advocates for unrestricted development and deployment of artificial intelligence. Regulation of artificial intelligence and government intervention in markets more generally is met with opposition. Many of its proponents have libertarian views and think that AGI will be most aligned if many AGIs compete against each other on the marketplace. The founders of the movement see it as rooted in Jeremy England's theory on the origin of life, which is focused on entropy and thermodynamics. According to them, the universe aims to increase entropy, and life is a way of increasing it. By spreading life throughout the universe and making life use up ever increasing amounts of energy, the universe's purpose would thus be fulfilled.
Sources: en.wikipedia.org
No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.
Preclinical rodent studies reported cancers, including liver and bladder tumors, at tested doses. The human relevance of those findings is uncertain, but development was discontinued. No approved human product resulted.
No. It remains an investigational compound without approved therapeutic labeling. Sports regulators prohibit its use, and health agencies have warned against consuming it.
It binds to and activates PPAR delta, a nuclear receptor that controls expression of genes related to fatty acid oxidation. This mechanism can alter energy metabolism in animal models. It is not a direct stimulant or fat-burning enzyme.